NCT05275179已完成不适用
Pharmacokinetic of Intravenous Posaconazole in Critically Ill Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Posaconazole Drug Exposure
研究概览
简要总结
The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.
详细描述
The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial. Plasma specimens will be retrieved on consecutive days (max. 7 days) in order to measure posaconazole levels during the treatment episode.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •treatment with intravenous posaconazole
- •critically ill patient
- •written declaration of consent
排除标准
- •no declaration of consent
结局指标
主要结局
Posaconazole Drug Exposure
时间窗: seven days from therapystart
Measurement of posaconazole concentration in serum
次要结局
- population-pharmacokinetic analysis 1(12 months after close out)
- population-pharmacokinetic analysis 2(12 months after close out)
- Evaluation of probability of target attainment of posaconazole(12 months after close out)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)NeutropeniaNCT02452034Merck Sharp & Dohme LLC118
已完成
2 期
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)Invasive AspergillosisNCT04218851Merck Sharp & Dohme LLC31
已完成
1 期
Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)Fungal InfectionNCT03336502Merck Sharp & Dohme LLC70
已完成
4 期
Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal InfectionsAllogeneic Stem Cell TransplantAcute Graft Versus Host DiseaseAcute Myeloid LeucaemiaMyelo Dysplastic SyndromeNCT02805946Radboud University Medical Center21
终止
4 期
A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)Fungal InfectionNCT01667107Merck Sharp & Dohme LLC26